(Boursier.com) — The biopharmaceutical company Genfit held its Combined General Meeting on May 24. The quorum met on first call was 29.54% and enabled all the resolutions to be approved, with the exception of resolution no. 26, for which the Board of Directors had recommended voting against.
©2023 Boursier.com